TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
黃凱文HUANG, KAI-WEN
- 計畫主持人
- 執行臨床試驗年資 22 年 9 個月
-
skywing@ntuh.gov.tw
發表文獻
23筆
11
Jayant K, Habib N, Huang KW, Warwick J, Arasaradnam R. Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma. Diagnostics (Basel). 2020 May 25;10(5):338. doi: 10.3390/diagnostics10050338. PMID: 32466214; PMCID: PMC7277978.
12
Yang PC, Huang KW, Pua U, Kim MD, Li SP, Li XY, Liang PC. Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer - A multi-institutional clinical study in Asia. Eur J Surg Oncol. 2020 May;46(5):811-817. doi: 10.1016/j.ejso.2019.12.006. Epub 2019 Dec 10. PMID: 31839436.
13
Jayant K, Habib N, Huang KW, Podda M, Warwick J, Arasaradnam R. Immunological Basis of Genesis of Hepatocellular Carcinoma: Unique Challenges and Potential Opportunities through Immunomodulation. Vaccines (Basel). 2020 May 23;8(2):247. doi: 10.3390/vaccines8020247. PMID: 32456200; PMCID: PMC7349974.
14
Huang KW, Reebye V, Czysz K, Ciriello S, Dorman S, Reccia I, Lai HS, Peng L, Kostomitsopoulos N, Nicholls J, Habib RS, Tomalia DA, Sætrom P, Wilkes E, Cutillas P, Rossi JJ, Habib NA. Liver Activation of Hepatocellular Nuclear Factor-4α by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic Profile. Mol Ther Nucleic Acids. 2020 Mar 6;19:361-370. doi: 10.1016/j.omtn.2019.10.044. Epub 2019 Nov 21. PMID: 31877412; PMCID: PMC6938799.
15
Hsiao CY, Teng X, Su TH, Lee PH, Kao JH, Huang KW. Improved quantitative assessment of HBV-associated liver fibrosis using second-harmonic generation microscopy with feature selection. Clin Res Hepatol Gastroenterol. 2020 Feb;44(1):12-20. doi: 10.1016/j.clinre.2019.04.003. Epub 2019 May 7. PMID: 31076362.
16
Hsiao CY, Yang PC, Li X, Huang KW. Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinoma. Sci Rep. 2020 Jul 2;10(1):10883. doi: 10.1038/s41598-020-67772-2. PMID: 32616770; PMCID: PMC7331634.
17
Hsiao CY, Chen PD, Huang KW. A Prospective Assessment of the Diagnostic Value of Contrast-Enhanced Ultrasound, Dynamic Computed Tomography and Magnetic Resonance Imaging for Patients with Small Liver Tumors. J Clin Med. 2019 Sep 1;8(9):1353. doi: 10.3390/jcm8091353. PMID: 31480576; PMCID: PMC6780634.
18
Huang KW, Jayant K, Lee PH, Yang PC, Hsiao CY, Habib N, Sodergren MH. Positive Immuno-Modulation Following Radiofrequency Assisted Liver Resection in Hepatocellular Carcinoma. J Clin Med. 2019 Mar 19;8(3):385. doi: 10.3390/jcm8030385. PMID: 30893948; PMCID: PMC6463076.
19
Holland MM, Bhutiani N, Kruse EJ, Weiss MJ, Christein JD, White RR, Huang KW, Martin RCG 2nd. A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from the AHPBA pancreatic registry. HPB (Oxford). 2019 Aug;21(8):1024-1031. doi: 10.1016/j.hpb.2018.12.004. Epub 2019 Feb 5. PMID: 30737097.
20
Yoon S, Huang KW, Andrikakou P, Vasconcelos D, Swiderski P, Reebye V, Sodergren M, Habib N, Rossi JJ. Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC. Mol Ther Nucleic Acids. 2019 Dec 6;18:142-154. doi: 10.1016/j.omtn.2019.08.017. Epub 2019 Aug 22. PMID: 31546149; PMCID: PMC6796740.
